General Information


DRAVP ID  DRAVPe01336

Peptide Name   hEP-1

Sequence  EELRVRLASHLRKLRKRLLRDADDLQKRLAVYEEQAQQIRLQAEAFQARLKSWFEPLVEDM

Sequence Length  61

UniProt ID  P02649 

Taxon ID  None

Source  Synthetic construct(derived from human apolipoprotein E)

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not available



Activity Information


Target Organism  HCV

Assay  RT PCR

Activity 

  • [Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=0.67 μM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref.22334503]Huh7.5.1 cell:CC50>100 μg/ ml(〜14μM).

Binding Target 

Mechanism  hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe01336

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C327H539N101O93S

Absent amino acids  CGNT

Common amino acids  L

Mass  7405.56

Pl  9.4

Basic residues  14

Acidic residues  11

Hydrophobic residues  25

Net charge  3

Boman Index  -18940

Hydrophobicity  -74.1

Aliphatic Index  102.46

Half Life 

  •     Mammalian:1 hour
  •     Yeast:30 min
  •     E.coli:>10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  116.5

Polar residues  3



Literature Information


Literature 1

Title   Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.

Pubmed ID   22334503

Reference   Hepatology. 2012 Aug;56(2):484-91.

Author   Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.

DOI   10.1002/hep.25665